These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 1663287)

  • 21. Comparative efficacy of three doses of the genetically engineered Aujeszky's disease virus vaccine strain 783 in pigs with maternal antibodies.
    Kimman TG
    Vaccine; 1992; 10(6):363-5. PubMed ID: 1317982
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intranasal vaccination of pigs against Aujeszky's disease: comparison with inactivated vaccines in pigs with low maternal antibody titres.
    De Leeuw PW; Van Oirschot JT
    Res Vet Sci; 1985 Jul; 39(1):34-8. PubMed ID: 2994188
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oronasal challenge of fattening pigs after vaccination with an inactivated Aujeszky's disease vaccine.
    Pensaert MB; Vandeputte J; Andries K
    Res Vet Sci; 1982 Jan; 32(1):12-6. PubMed ID: 6283610
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of vaccination on Aujeszky's disease virus and disease transmission.
    Donaldson AI; Wardley RC; Martin S; Harkness JW
    Vet Rec; 1984 Aug; 115(6):121-4. PubMed ID: 6089404
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intranasal vaccination of pigs against Aujeszky's disease. 4. Comparison with one or two doses of an inactivated vaccine in pigs with moderate maternal antibody titres.
    Van Oirschot JT; De Leeuw PW
    Vet Microbiol; 1985 Aug; 10(5):401-8. PubMed ID: 2996212
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of vaccination route on the efficacy of Aujeszky's disease deletion-mutant vaccine.
    Hasebe H; Osorio FA; Hogg A; Liauw H; Bartkoski MJ; Sugiyama M
    J Vet Med Sci; 1992 Aug; 54(4):693-8. PubMed ID: 1327180
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of active immunity in newborn pigs with colostral antibodies by vaccination with gIII-deleted PRV.
    Kit S; Kit M; McConnell S; Lawhorn B
    Acta Vet Hung; 1994; 42(2-3):319-30. PubMed ID: 7810426
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of a quadruple glycoprotein-deleted pseudorabies virus mutant for use as a biologically safe live virus vaccine.
    Mettenleiter TC; Klupp BG; Weiland F; Visser N
    J Gen Virol; 1994 Jul; 75 ( Pt 7)():1723-33. PubMed ID: 8021601
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vaccination of pigs against Aujeszky's disease by the intradermal route using live attenuated and inactivated virus vaccines.
    Vannier P; Cariolet R
    Zentralbl Veterinarmed B; 1989 Sep; 36(7):515-26. PubMed ID: 2554623
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protection of pigs against Aujeszky's disease by DNA vaccination.
    Gerdts V; Jöns A; Makoschey B; Visser N; Mettenleiter TC
    J Gen Virol; 1997 Sep; 78 ( Pt 9)():2139-46. PubMed ID: 9291999
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Vaccination of sheep against Aujeszky's disease with a gI-deleted mutant].
    Bruchhof BR; Straub OC
    Dtsch Tierarztl Wochenschr; 1992 Aug; 99(8):322-5. PubMed ID: 1330479
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel concept for the control of Aujeszky's disease: experiences in two vaccinated pig herds.
    van Oirschot JT; Wijsmuller JM; de Waal CA; van Lith PM
    Vet Rec; 1990 Feb; 126(7):159-63. PubMed ID: 2155499
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Constancy of Aujeszky's field virus antibody titres in sows repeatedly vaccinated with a gI-negative vaccine.
    Hopp W; Jungblut R
    Acta Vet Hung; 1994; 42(2-3):409-11. PubMed ID: 7810439
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Trial of vaccination against Aujeszky's disease].
    Motovski A; Veselinova A; Dobrev V
    Vet Med Nauki; 1980; 17(5):32-7. PubMed ID: 6262995
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Virological protection of sows upon challenge with Aujeszky's disease virus after multiple vaccinations with attenuated or inactivated vaccines.
    Nauwynck HJ; Zonnekeyn V; Pensaert MB
    Zentralbl Veterinarmed B; 1997 Dec; 44(10):609-15. PubMed ID: 9467303
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Experimental infection of fattening pigs with pseudorabies (Aujeszky's disease) virus: efficacy of attenuated live- and inactivated-virus vaccines in pigs with or without passive immunity.
    Vannier P
    Am J Vet Res; 1985 Jul; 46(7):1498-502. PubMed ID: 2992327
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A study of the ability of a TK-negative and gI/gE-negative pseudorabies virus (PRV) mutant inoculated by different routes to protect pigs against PRV infection.
    Ferrari M; Brack A; Romanelli MG; Mettenleiter TC; Corradi A; Dal Mas N; Losio MN; Silini R; Pinoni C; Pratelli A
    J Vet Med B Infect Dis Vet Public Health; 2000 Dec; 47(10):753-62. PubMed ID: 11204130
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Vaccination in Aujeszky's disease on enzootic fattening farms].
    Motovski A; Veselinova A; Shalamanov D
    Vet Med Nauki; 1980; 17(4):23-9. PubMed ID: 6259802
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of parenteral vaccination methods with glycoproteins against Aujeszky's disease in pigs.
    Vanderpooten A; Goddeeris B; De Roose P; Hendrickx L; Biront P; Desmettre P
    Vet Microbiol; 1997 Apr; 55(1-4):81-9. PubMed ID: 9220599
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-transmissible pseudorabies virus gp50 mutants: a new generation of safe live vaccines.
    Peeters B; Bouma A; de Bruin T; Moormann R; Gielkens A; Kimman T
    Vaccine; 1994 Mar; 12(4):375-80. PubMed ID: 8178562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.